Literature DB >> 6546694

Studies on the kinetics of binding of complement-fixing dsDNA/anti-dsDNA immune complexes to the red blood cells of normal individuals and patients with systemic lupus erythematosus.

C Horgan, R P Taylor.   

Abstract

The kinetics of binding of prepared complement opsonized 3H-dsDNA/anti-DNA immune complexes to normal red blood cells (RBCs) and to RBCs with lowered immune complex binding capacity from certain patients with systemic lupus erythematosus (SLE) or rheumatoid arthritis was examined. Normal RBCs bound the immune complexes rapidly and reached equilibrium in about 4 minutes at 37 degrees C, while the SLE RBCs not only bound less immune complex but required up to 30 minutes to reach equilibrium. Chemical modification of normal RBCs with moderate amounts of dithiothreitol, an agent that destroys the binding activity of the C3b receptor (CR1), produced RBCs that mimicked the equilibrium and kinetic binding properties of the SLE RBCs. These observations, taken in conjunction with a detailed examination of the temperature dependence of the binding kinetics, suggest that CR1 reorganization on the RBC surface to form binding clusters may be an essential step in the complement mediated binding of immune complexes to RBCs. The implications of these findings with respect to the clearance of immune complexes from the circulation of patients with autoimmune diseases are discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6546694     DOI: 10.1002/art.1780270312

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  8 in total

1.  LDL-mediated interaction of DNA and DNA-anti-DNA immune complexes with cell surface.

Authors:  A E Kabakov; V A Saenko; A M Poverenny
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

2.  Red cell associated, naturally occurring anti-spectrin antibodies.

Authors:  H U Lutz; R Flepp; P Stammler; R Baccalà
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

Review 3.  Complement activation and complement receptors in systemic lupus erythematosus.

Authors:  J P Atkinson
Journal:  Springer Semin Immunopathol       Date:  1986

Review 4.  CR1 and the cell membrane proteins that bind C3 and C4. A basic and clinical review.

Authors:  J G Wilson; N A Andriopoulos; D T Fearon
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

5.  Complement-component-C3-opsonized immunoglobulin G anti-DNA antibodies do not bind effectively to red blood cells unless aggregated on a high-Mr DNA matrix.

Authors:  C Horgan; R P Taylor
Journal:  Biochem J       Date:  1984-12-15       Impact factor: 3.857

6.  Autoantibody to the C3b/C4b receptor and absence of this receptor from erythrocytes of a patient with systemic lupus erythematosus.

Authors:  J G Wilson; R M Jack; W W Wong; P H Schur; D T Fearon
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

7.  Erythrocytes from young but not elderly donors can bind and degrade immune complex- and antibody-bound C3 in vitro.

Authors:  S Shapiro; D Kohn; B Miller; H Gershon
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

8.  In vivo handling of soluble complement fixing Ab/dsDNA immune complexes in chimpanzees.

Authors:  R P Kimberly; J C Edberg; L T Merriam; S B Clarkson; J C Unkeless; R P Taylor
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.